Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Schennach-Wolff

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Psychiatry Research|January 23, 2010
Extensive elevation of creatine kinase with generic clozapine, but not with LeponexRebecca Schennach-Wolff, Susanne Stübner, Michael Riedel, et al.
Evidence-Based Mental Health|August 23, 2011
Review: antidepressants associated with increased risk of suicidality in adults aged less than 25 yearsFlorian Seemüller, Hans-Jürgen Möller, Michael Obermeier, et al.
Schizophrenia Bulletin|November 6, 2009
Should the PANSS be rescaled?Michael Obermeier, Andreas Mayr, Rebecca Schennach-Wolff, et al.
Expert Opinion on Drug Safety|May 22, 2010
Safety evaluation of zotepine for the treatment of schizophreniaMichael Riedel, Richard Musil, Florian Seemüller, et al.
Journal of Affective Disorders|November 6, 2009
Does early improvement in major depression protect against treatment emergent suicidal ideation?Florian Seemüller, Rebecca Schennach-Wolff, Michael Obermeier, et al.
BMC Psychiatry|July 20, 2011
Is the PANSS used correctly? a systematic reviewMichael Obermeier, Rebecca Schennach-Wolff, Sebastian Meyer, et al.
Journal of Clinical Psychopharmacology|December 31, 2010
Effectiveness of quetiapine in outpatients with schizophrenia assessed under "real-life" conditions: a German clinical-practice evaluation programmeMichael Riedel, Emanuel Severus, Rebecca Schennach-Wolff, et al.
Schizophrenia Research|June 24, 2010
Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatmentNorbert Müller, Daniela Krause, Sandra Dehning, et al.
Journal of Affective Disorders|May 11, 2011
Clinical predictors of response and remission in inpatients with depressive syndromesMichael Riedel, Hans-Jürgen Möller, Michael Obermeier, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|May 17, 2011
Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidolMichael Riedel, Andreas Mayr, Florian Seemüller, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Psychiatry Research|January 23, 2010
Extensive elevation of creatine kinase with generic clozapine, but not with LeponexRebecca Schennach-Wolff, Susanne Stübner, Michael Riedel, et al.
Evidence-Based Mental Health|August 23, 2011
Review: antidepressants associated with increased risk of suicidality in adults aged less than 25 yearsFlorian Seemüller, Hans-Jürgen Möller, Michael Obermeier, et al.
Schizophrenia Bulletin|November 6, 2009
Should the PANSS be rescaled?Michael Obermeier, Andreas Mayr, Rebecca Schennach-Wolff, et al.
Expert Opinion on Drug Safety|May 22, 2010
Safety evaluation of zotepine for the treatment of schizophreniaMichael Riedel, Richard Musil, Florian Seemüller, et al.
Journal of Affective Disorders|November 6, 2009
Does early improvement in major depression protect against treatment emergent suicidal ideation?Florian Seemüller, Rebecca Schennach-Wolff, Michael Obermeier, et al.
BMC Psychiatry|July 20, 2011
Is the PANSS used correctly? a systematic reviewMichael Obermeier, Rebecca Schennach-Wolff, Sebastian Meyer, et al.
Journal of Clinical Psychopharmacology|December 31, 2010
Effectiveness of quetiapine in outpatients with schizophrenia assessed under "real-life" conditions: a German clinical-practice evaluation programmeMichael Riedel, Emanuel Severus, Rebecca Schennach-Wolff, et al.
Schizophrenia Research|June 24, 2010
Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatmentNorbert Müller, Daniela Krause, Sandra Dehning, et al.
Journal of Affective Disorders|May 11, 2011
Clinical predictors of response and remission in inpatients with depressive syndromesMichael Riedel, Hans-Jürgen Möller, Michael Obermeier, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|May 17, 2011
Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidolMichael Riedel, Andreas Mayr, Florian Seemüller, et al.
Pageof 2